While our initial focus is on aggressive brain tumors and our secondary focus is on tumors outside the brain, SONALA-001 in combination with MR-guided focused ultrasound has the potential to treat the majority of tumors of epithelial origin: gliomas, meningiomas, pancreatic, ovarian, gastric, bladder, skin, esophageal, lung, gall bladder, and breast cancer.